These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 25199765)

  • 1. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma.
    Desjardins LA
    Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapies for hepatocellular carcinoma.
    Ge S; Huang D
    Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for targeted therapies in hepatocellular carcinoma.
    Thomas MB; Abbruzzese JL
    J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapies in hepatocellular carcinoma: present and future.
    Bertino G; Di Carlo I; Ardiri A; Calvagno GS; Demma S; Malaguarnera G; Bertino N; Malaguarnera M; Toro A; Malaguarnera M
    Future Oncol; 2013 Oct; 9(10):1533-48. PubMed ID: 24106903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV-related HCC, clinical issues and therapy.
    Iavarone M; Colombo M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S32-9. PubMed ID: 21195370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
    Lord R; Suddle A; Ross PJ
    Int J Clin Pract; 2011 Feb; 65(2):182-8. PubMed ID: 21235699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
    Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
    J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma.
    Naugler WE; Schwartz JM
    Dis Mon; 2008 Jul; 54(7):432-44. PubMed ID: 18570913
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy.
    Yaghmai V; Besa C; Kim E; Gatlin JL; Siddiqui NA; Taouli B
    AJR Am J Roentgenol; 2013 Jul; 201(1):80-96. PubMed ID: 23789661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and emerging therapies for hepatocellular carcinoma.
    Cicinnati VR; Sotiropoulos GC; Beckebaum S
    Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.